#LSD1
Histone lysine demethylases in the third decade: biology and therapeutic prospects
www.nature.com/articles/s41...
rdcu.be/CUdZDsYKESpa

This new Review covers the therapeutic landscape for inhibitors of enzymes such as LSD1 (KDM1A), which are in clinical trials for cancer and other diseases
Histone lysine demethylases in the third decade: biology and therapeutic prospects - Nature Reviews Drug Discovery
Histone lysine demethylases regulate gene expression and chromatin structure and help to integrate epigenetics with metabolic and immune responses. This Review discusses the diverse contributions of t...
www.nature.com
November 10, 2026 at 3:53 PM
Dr Rafa Madero-Marroquin will present interim results from our trial looking at HMA + iadademstat (LSD1 inhibitor) in accelerated/blast-phase MPNs!

onlineprogram.hematology.org/paper-detail...
November 9, 2026 at 1:48 AM
Global repression of mesenchymal genes in epithelial cells by the histone demethylase LSD1 https://www.biorxiv.org/content/10.64898/2026.11.04.764245v1
November 6, 2026 at 12:19 PM
Global repression of mesenchymal genes in epithelial cells by the histone demethylase LSD1 https://www.biorxiv.org/content/10.64898/2026.11.04.764245v1
November 6, 2026 at 12:19 PM
RRID:AB_2556781 from @thermofishersci.bsky.social was used by authors in their Molecular Biomedicine paper. Thanks for making your methods matter! #accelerateopenscience #ReproducibleResearch #BetterScience
Lysine-specific demethylase 1 (LSD1) regulates macrophage plasticity and immune checkpoint expression in colorectal liver metastases
Read the full paper: Lysine-specific demethylase 1 (LSD1) regulates macrophage plasticity and immune checkpoint expression in colorectal liver metastases
doi.org
October 30, 2026 at 7:08 AM
A novel high-throughput method using NIR-BiFC-Seq identifies LSD1 as a key regulator enhancing SARS-CoV-2 production by demethylating viral nucleocapsid protein at K233.

🔗 Source: https://pubmed.ncbi.nlm.nih.gov/42933642/
October 28, 2026 at 6:59 AM
Epigenetic regulation of vascular #SmoothMuscleCell plasticity in vascular injury, repair & aging

PRMT5, EZH2, LSD1, CBP/P300, heterochromatin, BRD4

Happy to contribute a bit (Mechano-epigenetics; Aneurysm) to this review by my PhD supervisor😁

#VasPharma 2026
www.sciencedirect.com/science/arti...
October 25, 2026 at 7:49 PM
October 18, 2026 at 5:45 PM
ET trials have moved beyond aspirin plus hydroxyurea: ropeginterferon, the LSD1 inhibitor bomedemstat and mutant-CALR antibodies all target the disease, not just the platelet count. The open question is which end point (molecular response, thrombosis, or MF progression) regulators will accept.
October 15, 2026 at 7:21 PM
The authors included RRIDs in their in Journal of Clinical Investigation paper! Thanks for making your methods matter! #BetterScience #RRID #accelerateopenscience
LSD1-mediated demethylation of the DNA damage response factor ATM promotes senescence and organ aging
Read the full paper: LSD1-mediated demethylation of the DNA damage response factor ATM promotes senescence and organ aging
doi.org
October 7, 2026 at 7:02 AM
Could targeting LSD1 be a novel strategy to decrease senescence, organ aging, and hair graying? doi.org/10.1172/JCI1...

Zhang et al. demonstrate LSD1 as a key regulator of DNA damage-induced senescence and organ aging and highlights it as a promising therapeutic target.
September 30, 2026 at 3:03 PM
In this working model inhibition of LSD1 by its specific inhibitor ORY-
1001 could reduce LSD1 expression, and treatment with senolytic drugs (Dasatinib and Quercetin) could ameliorate cellular senescence and organ aging.
September 30, 2026 at 3:03 PM
Oryzon's LSD1 inhibitor iadademstat paired with gilteritinib for AML has won US patent allowance. Protection runs to 2042 once formally granted, covering the combination for myeloid cancers.
Oryzon wins US patent allowance for iadademstat-gilteritinib AML combo
The USPTO notice covers LSD1 inhibitor combinations for myeloid cancers, with protection expected to run to 2042 pending formal grant.
biotech.disruptsmedia.com
September 12, 2026 at 6:10 PM
Amoeba's What's in My Bag?

November 22, 2010

Mike Kelley

#musicsky

www.youtube.com/watch?v=lsd1...
Mike Kelley - What's In My Bag?
YouTube video by Amoeba
www.youtube.com
September 4, 2025 at 3:48 AM
Sims 2 DS was so good the OST did not have to go THIS HARD

www.youtube.com/watch?v=LSD1...
The Sims 2 (DS) Music - Techno
YouTube video by FreakRacer101
www.youtube.com
September 16, 2025 at 2:33 PM
New app note! 📄
Working with a key intermediate from the Harvard Liau Group, we achieved high-throughput chiral separation using CHIRALPAK® IK—100 mg/hr on a 4.6 mm column.
🔗 chiraltech.com/wp-content/u...
#ChiralSeparation #LSD1 #CancerResearch #Harvard #HPLC #DrugDiscovery
May 15, 2025 at 5:12 PM
🌱 #SeminarSeriesCBGP

🗓️ 05/06/26 - 12:30
👨‍🔬 Dr. José Manuel Pérez-Pérez
📰 Functional analysis of plant LSD1/KDM1A proteins
💻 Zoom: bit.ly/3Ph5CIP (🔐627464)
🏛️ Instituto de Bioingeniería (Universidad Miguel Hernández de Elche)

#Research #PlantScience #PlantBiology
June 1, 2026 at 10:35 AM
Revealing lysine-specific histone demethylase 1a as a new target for kidney diseases

Tobias B. Huber & team show LSD1 regulates kidney development, and its dysfunction disrupts key kidney cells, leading to cyst formation in mouse and organoid models: doi.org/10.1172/jci....
March 20, 2026 at 11:02 AM


Altered chromatin accessibility and nucleosome positioning landscape upon HDAC and LSD1 inhibition in cancer cell

https://www.biorxiv.org/content/10.64898/2026.04.08.717275v1
April 20, 2026 at 1:01 PM


Altered chromatin accessibility and nucleosome positioning landscape upon HDAC and LSD1 inhibition in cancer cell

https://www.biorxiv.org/content/10.64898/2026.04.08.717275v1
April 13, 2026 at 1:12 PM
Inhibition of the lysine demethylase LSD1 modulates the balance between inflammatory and antiviral responses against coronaviruses www.science.org/doi/10.1126/...
Inhibition of the lysine demethylase LSD1 modulates the balance between inflammatory and antiviral r...
LSD1 inhibition blocks the inflammatory response to coronaviruses but spares the interferon response.
www.science.org
December 20, 2023 at 2:28 PM